Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mobilore-AQ Injection

Prescription Icon
Prescription Required

Marketer

Hublore Healthcare Pvt Ltd

Salt Composition

Diclofenac (75mg)

Overview Mobilore-AQ Injection

Aquesol injection provides analgesia. Indicated for pain management, inflammation, and stiffness associated with rheumatoid arthritis, osteoarthritis, and acute musculoskeletal trauma, it's administered parenterally when oral routes are infeasible. Injection must be given by a healthcare provider; self-administration is strictly prohibited. Patients with a history of cardiovascular events (stroke or heart disease) should inform their physician. Report any injection site reactions (pain, swelling, erythema) immediately. Common adverse effects encompass nausea, vomiting, headache, and injection site reactions. For prolonged therapy, regular monitoring of renal and hepatic function, along with blood counts, is recommended. Chronic use carries a risk of serious complications, including gastrointestinal bleeding and nephropathy.

Primary Ingredients of Mobilore-AQ Injection

No text provided. Please provide the text you wish me to rephrase.

Uses of Mobilore-AQ Injection

Analgesia

Major Benefits of Mobilore-AQ Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Mobilore-AQ Injection:

  • Injection site reactions (pain, swelling, redness)
  • Vomiting
  • Flatulence
  • Edema (swelling)
  • Nausea
  • Headache
  • Dizziness

How to use Mobilore-AQ Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Mobilore-AQ Injection works:

Aquamotil Injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of specific inflammatory mediators responsible for pain and associated inflammation, such as redness and edema.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Mobilore-AQ Injection concurrently with alcohol. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Mobilore-AQ Injection during pregnancy is contraindicated due to confirmed risks to the fetus. Exceptions may exist in life-threatening emergencies where the potential benefits outweigh the inherent dangers, as determined by a physician. Physician consultation is mandatory.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Mobilore-AQ Injection while breastfeeding is likely unsafe. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Administering Mobilore-AQ Injection may impair driving ability due to potential adverse reactions.

KidneyKidneyCAUTION

Administering Mobilore-AQ Injection to individuals with renal impairment requires careful consideration. A modified dosage of Mobilore-AQ Injection might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Exercise caution when administering Mobilore-AQ Injection to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Mobilore-AQ Injection :

Omit a Mobilore-AQ Injection dose? Seek your physician's advice.

Facts to Know About Mobilore-AQ Injection

LabelValue
Chemical Category Phenylacetic Acid Analog
Developing Habits No.
Treatment Category Pain Relievers

FAQs on Mobilore-AQ Injection

Mobilore-AQ Injection must be administered only by a healthcare professional via intramuscular (preferably in the buttock), subcutaneous, or intravenous (bolus only, not infusion) routes. The prescribed dose should not be exceeded, and treatment should not continue beyond two days.
Mobilore-AQ Injection may increase your risk of heart attack or stroke, particularly with higher doses or prolonged use. It can also cause stomach and intestinal ulcers, bleeding, or perforation, potentially fatal and without warning. Seek immediate medical attention if such problems arise.
Mobilore-AQ Injection provides effective pain and inflammation relief. Its applications include sprains, strains, other injuries, various arthritic conditions, gout, and post-surgical pain and inflammation.
Mobilore-AQ Injection, when used long-term or at high doses, can lead to renal issues like proteinuria, hematuria, and dysuria. Individuals with pre-existing conditions increasing renal risk—dehydration, heart failure, impaired kidney function, hypertension, advanced age, or use of diuretics or nephrotoxic medications—should have their kidney function closely monitored.
Mobilore-AQ Injection may cause drowsiness, dizziness, fatigue, and visual disturbances, though these side effects are uncommon. If you experience any of these, refrain from driving or operating machinery.
Avoid Mobilore-AQ Injection during pregnancy, especially the last trimester, due to potential harm to the baby and the risk of premature labor. Its use should also be avoided during the first six months. Only a doctor can determine if the benefits outweigh the risks in specific circumstances. Always consult your doctor before using Mobilore-AQ Injection if you are pregnant.
Mobilore-AQ Injection is not a recreational drug; it has no potential for abuse or dependence. If you experience any adverse effects, seek medical advice.
Mobilore-AQ Injection is not a narcotic; it's a non-steroidal anti-inflammatory drug (NSAID).
Mobilore-AQ Injection
16
MRP 19
15% off